Literature DB >> 2350086

Analysis of HLA antigens in patients with diffuse panbronchiolitis.

Y Sugiyama1, S Kudoh, H Maeda, H Suzaki, F Takaku.   

Abstract

A new clinicopathologic entity, diffuse panbronchiolitis, was recently reported in Japan. This disorder is characterized by recurrent sinopulmonary infection and respiratory bronchiolitis. We identified cases of familial diffuse panbronchiolitis and found that many siblings of the patients had paranasal sinusitis. Because of this, we performed HLA analysis of the patients with diffuse panbronchiolitis. In HLA Class I and Class II antigens, Bw54 significantly increased (frequency: 63.2%; RR = 13.30; corrected p value less than 1.08 x 10(-10], whereas Cw1 and MC1 (a new HLA-DR-related antigen) slightly increased. These increases might be explained by the fact that these two antigens, Cw1 and MC1, formed a haplotype with Bw54, which suggests that one or some of the genes controlling the susceptibility and/or immune responsiveness of diffuse panbronchiolitis might be located near HLA loci. In addition, Bw54, or its related haplotype, exists only in Japanese, Chinese, and Korean populations. This may explain why a similar disease had not been reported in the English literature.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350086     DOI: 10.1164/ajrccm/141.6.1459

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan.

Authors:  M Tanaka; Y Kawaguchi; J Yokofujita; M Takagi; Y Eishi; K Hirai
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Chronic transmural bronchiolitis: a non-specific lesion of small airways.

Authors:  C Edwards; R Cayton; R Bryan
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

3.  Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis.

Authors:  Minako Hijikata; Ikumi Matsushita; Goh Tanaka; Tomoko Tsuchiya; Hideyuki Ito; Katsushi Tokunaga; Jun Ohashi; Sakae Homma; Yoichiro Kobashi; Yoshio Taguchi; Arata Azuma; Shoji Kudoh; Naoto Keicho
Journal:  Hum Genet       Date:  2010-10-28       Impact factor: 4.132

Review 4.  Erythromycin and diffuse panbronchiolitis.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

5.  Diffuse panbronchiolitis in an Asian immigrant.

Authors:  O Brugiere; B Milleron; M Antoine; M F Carette; C Philippe; C Mayaud
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

Review 6.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

7.  The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases.

Authors:  Ding Hui; Fen Yan; Ru-Hua Chen
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

8.  Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis.

Authors:  N Keicho; J Ohashi; G Tamiya; K Nakata; Y Taguchi; A Azuma; N Ohishi; M Emi; M H Park; H Inoko; K Tokunaga; S Kudoh
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 9.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

10.  Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.

Authors:  J Tamaoki; A Chiyotani; E Tagaya; N Sakai; K Konno
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.